To the left of the image, a Black man with a beard, and hidradenitis suppurativa (HS), poses facing the camera with his tattooed chest exposed, showing scars from his HS flares. To his left reads a headline: "HS TRUTH: Patients are ready for more. Let's raise the bar in HS care". Below the headline is a tag with the patient's name which reads "Jawan, real HS patient."
To the left of the image, a Black man with a beard, and hidradenitis suppurativa (HS), poses facing the camera with his tattooed chest exposed, showing scars from his HS flares. To his left reads a headline: "HS TRUTH: Patients are ready for more. Let's raise the bar in HS care". Below the headline is a tag with the patient's name which reads "Jawan, real HS patient."
Parish, real HS patient.

For patients with moderate to severe HS, it’s more than just a skin condition—it’s a chronic, painful reminder of its impact on their overall well-being. From reduced quality of life to emotional distress, HS takes a heavy toll. And while patients carry the heaviest burden, managing the condition presents its own challenges for providers. Incyte is committed to advancing HS care and addressing the needs of all those impacted by this chronic inflammatory condition.1

HS: The Truths You Don’t Always Hear.

Nothing to hide. Everything to say. The Naked Truths documentary helps bridge the gap between clinical care and the lived experience of patients with HS.

4 individuals looking straight at the camera. There is a green play button layered on top of the image
A White woman who has brown hair poses looking into the camera with her right arm up, showing scars from her hidradenitis suppurativa (HS) flares.

Not seeing results?

It's time to rethink treatment

See gaps in HS care
A White woman who has blonde hair poses looking into the camera lifting up her shirt, showing scars from her hidradenitis suppurativa (HS) flares under her right breast.

HS goes deeper than the skin2

so should our understanding

Go below the surface
A Black man, with hidradenitis suppurativa (HS), poses with a look of defiance into the camera.

Uncover the hidden burdens behind visible symptoms3

Explore the full impact

“I am optimistic about the future of HS with our treatments. Partnering with companies like Incyte can empower our community and our patients.”

—Dermatologist, Texas

Connect with us

HS, hidradenitis suppurativa.

REFERENCES: 1. Hamzavi IH, Sundaram M, Nicholson C, et al. Uncovering burden disparity: a comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa. J Am Acad Dermatol. 2017;77(6):1038-1046. doi:10.1016/j.jaad.2017.07.027 2. Sabat R, Alavi A, Wolk K, et al. Hidradenitis suppurativa. Lancet. 2025;405(10476):420-438. doi:10.1016/S0140-6736(24)02475-9 3. Garg A, Neuren E, Cha D, et al. Evaluating patients’ unmet needs in hidradenitis suppurativa: results from the Global Survey of Impact and Healthcare Needs (VOICE) project. J Am Acad Dermatol. 2020;82(2):366-376. doi:10.1016/j.jaad.2019.06.1301